Clinical Trials Directory

Trials / Unknown

UnknownNCT05066659

Balance Performance and Corticomotor Inhibition in PD

Relationship Between Balance Performance and Corticomotor Inhibition in Individuals With Parkinsons' Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
National Yang Ming Chiao Tung University · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Postural instability is one of the motor features of Parkinson's disease (PD). Most patients will develop balance dysfunction, and they may get worse with disease progression. According to previous studies, people with PD had abnormal changes in corticomotor excitability, especially disinhibition in the primary motor cortex (M1). Some evidence had shown that the cortical function in the M1 is crucial for the pathophysiology of the underlying motor symptoms in PD. Furthermore, neurostimulation over the M1 could modulate the corticomotor excitability in individuals with PD, and then improve their motor and also balance performance. However, whether the impaired corticomotor inhibition relates to balance dysfunction in people with PD is still unknown. In this study, the purpose is to investigate the possible relationship between corticomotor inhibition and balance performance in individuals with PD. However, the postural position during TMS measurement may affect the corticomotor excitability. To further establish the above-mentioned relationship, the secondary purpose is to explore and confirm whether the postural position will influence the correlation.

Conditions

Timeline

Start date
2021-10-08
Primary completion
2022-09-08
Completion
2022-09-08
First posted
2021-10-04
Last updated
2021-10-04

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05066659. Inclusion in this directory is not an endorsement.